Answers are grounded in this paper and cite their sources.
Cardiovascular disease is the leading cause of mortality worldwide, and India bears a disproportionately high burden, with higher mortality rates than in the rest of the world, and the onset of the disease occurs much earlier than in Western populations. Ischemic myocardial injuryare often linked as pathological conditions associated with oxidative stress, inflammation, and lipid dysfunction. Although conventional single-target pharmacotherapy is effective, it is limited by an inability to target these processes simultaneously, adverse-effect burden, and cost. Although most of the reported combinations are polyherbal, the formulations are not chemically standardized, and most of them are not tested for safety and efficacy in a single investigation. Vitex negundo, Abutilon indicum, and Gloriosa superba are three herbs that have individual pharmacological evidence based on the presence of the marker compounds agnuside, luteolin, and colchicine in each, but no previous study has brought all three together in a single standardized formulation. Therefore, the present work was undertaken to prepare and evaluate such a formulation from the root material of these three species.
No takes yet. Share an insight, caveat, or question.
Chandel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: